AAAAAA

   
Results: 1-14 |
Results: 14
MUSCARINIC RECEPTOR SUBTYPES IN PORCINE DETRUSOR - COMPARISON WITH HUMANS AND REGULATION BY BLADDER AUGMENTATION
Authors: GOEPEL M GRONEWALD A KREGE S MICHEL MC
Citation: M. Goepel et al., MUSCARINIC RECEPTOR SUBTYPES IN PORCINE DETRUSOR - COMPARISON WITH HUMANS AND REGULATION BY BLADDER AUGMENTATION, Urological research, 26(2), 1998, pp. 149-154
PROSPECTIVE RANDOMIZED MULTICENTER PHASE-II STUDY FOR ADVANCED BLADDER-CANCER - CISPLATIN PLUS METHOTREXATE + - FACTOR AF2/
Authors: KREGE S OTTO T HINKE A GOEPEL M RUBBEN H
Citation: S. Krege et al., PROSPECTIVE RANDOMIZED MULTICENTER PHASE-II STUDY FOR ADVANCED BLADDER-CANCER - CISPLATIN PLUS METHOTREXATE + - FACTOR AF2/, The Journal of urology, 159(5), 1998, pp. 637-637
LONG-TERM RESULTS OF OPERATIVE THERAPY FO R METASTASIZED NONSEMINOMATOUS GERM-CELL TUMORS (NSGT) IN ADVANCED TUMOR STAGES
Authors: OTTO T KREGE S GOEPEL M BASCHEK R RUBBEN H
Citation: T. Otto et al., LONG-TERM RESULTS OF OPERATIVE THERAPY FO R METASTASIZED NONSEMINOMATOUS GERM-CELL TUMORS (NSGT) IN ADVANCED TUMOR STAGES, Der Urologe, 36(4), 1997, pp. 339-342
2ND-LINE CHEMOTHERAPY WITH MITOMYCIN-C AN D 5-FLUOROURACIL IN THE TREATMENT OF REFRACTORY METASTATIC CANCER OF THE URINARY-BLADDER
Authors: OTTO T KREGE S OTTO B GOEPEL M RUBBEN H
Citation: T. Otto et al., 2ND-LINE CHEMOTHERAPY WITH MITOMYCIN-C AN D 5-FLUOROURACIL IN THE TREATMENT OF REFRACTORY METASTATIC CANCER OF THE URINARY-BLADDER, Der Urologe, 36(3), 1997, pp. 243-247
PHASE-II STUDY - ADJUVANT SINGLE-AGENT CARBOPLATIN THERAPY FOR CLINICAL STAGE-I SEMINOMA
Authors: KREGE S KALUND G OTTO T GOEPEL M RUBBEN H
Citation: S. Krege et al., PHASE-II STUDY - ADJUVANT SINGLE-AGENT CARBOPLATIN THERAPY FOR CLINICAL STAGE-I SEMINOMA, European urology, 31(4), 1997, pp. 405-407
PACLITAXEL-BASED 2ND-LINE THERAPY FOR PATIENTS WITH ADVANCED CHEMOTHERAPY-RESISTANT BLADDER-CARCINOMA (M1) - A CLINICAL-PHASE-II STUDY
Authors: OTTO T BEX A KREGE S WALZ PH RUBBEN H
Citation: T. Otto et al., PACLITAXEL-BASED 2ND-LINE THERAPY FOR PATIENTS WITH ADVANCED CHEMOTHERAPY-RESISTANT BLADDER-CARCINOMA (M1) - A CLINICAL-PHASE-II STUDY, Cancer, 80(3), 1997, pp. 465-470
PARAMETERS OF TUMOR PROGRESSION AND METASTASES IN BLADDER CARCINOMAS
Authors: OTTO T GOEPEL M KREGE S RUBBEN H
Citation: T. Otto et al., PARAMETERS OF TUMOR PROGRESSION AND METASTASES IN BLADDER CARCINOMAS, Onkologie, 19(1), 1996, pp. 24-30
URINARY-DIVERSION - SHOULD THE DECISION W HETHER TO OPERATE BE MADE ON A CASE-BY-CASE BASIS - INDICATIONS AND OUTCOME IN 200 CONSECUTIVE PATIENTS
Authors: KREGE S GOEPEL M MEYERSCHWICKERATH M OTTO T RUBBEN H
Citation: S. Krege et al., URINARY-DIVERSION - SHOULD THE DECISION W HETHER TO OPERATE BE MADE ON A CASE-BY-CASE BASIS - INDICATIONS AND OUTCOME IN 200 CONSECUTIVE PATIENTS, Der Urologe, 35(4), 1996, pp. 291-296
TREATMENT OF HORMONE-REFRACTORY CARCINOMA OF THE PROSTATE WITH MITOXANTRONE
Authors: OTTO T REMBRINK K GOEPEL M KREGE S MEYERSCHWICKERATH M RUBBEN H
Citation: T. Otto et al., TREATMENT OF HORMONE-REFRACTORY CARCINOMA OF THE PROSTATE WITH MITOXANTRONE, Der Urologe, 35(2), 1996, pp. 142-145
RESULTS OF POSTCHEMOTHERAPY ADJUNCTIVE RETROPERITONEAL LYMPH-NODE DISSECTION IN NONSEMINOMATOUS GERM-CELL CANCER-PATIENTS
Authors: GOEPEL M RECKER F OTTO T KREGE S RUBBEN H
Citation: M. Goepel et al., RESULTS OF POSTCHEMOTHERAPY ADJUNCTIVE RETROPERITONEAL LYMPH-NODE DISSECTION IN NONSEMINOMATOUS GERM-CELL CANCER-PATIENTS, Urologia internationalis, 57(4), 1996, pp. 209-212
A RANDOMIZED MULTICENTER TRIAL OF ADJUVANT THERAPY IN SUPERFICIAL BLADDER-CANCER - TRANSURETHRAL RESECTION ONLY VERSUS TRANSURETHRAL RESECTION PLUS MITOMYCIN-C VERSUS TRANSURETHRAL RESECTION PLUS BACILLUS-CALMETTE-GUERIN
Authors: KREGE S GIANI G MEYER R OTTO T RUBBEN H NOLL F JAKSE G MELCHIOR HJ WEISSBACH L TERHORST B LENZ P FAUL P SOMMERKAMP H KOPPER B HAUTMANN R KNEBEL L EISENBERGER F SCHAFFNER W
Citation: S. Krege et al., A RANDOMIZED MULTICENTER TRIAL OF ADJUVANT THERAPY IN SUPERFICIAL BLADDER-CANCER - TRANSURETHRAL RESECTION ONLY VERSUS TRANSURETHRAL RESECTION PLUS MITOMYCIN-C VERSUS TRANSURETHRAL RESECTION PLUS BACILLUS-CALMETTE-GUERIN, The Journal of urology, 156(3), 1996, pp. 962-966
AN INTRAOPERATIVE SEMINAL AND PROSTATE EMISSION TEST AS A CONTROL FORNERVE-SPARING PROCEDURES IN PRIMARY AND SECONDARY RETROPERITONEAL LYMPHADENECTOMY
Authors: RECKER F GOEPEL M OTTO T KREGE S WERNLI M STUCKI P TSCHOLL R RUBBEN H
Citation: F. Recker et al., AN INTRAOPERATIVE SEMINAL AND PROSTATE EMISSION TEST AS A CONTROL FORNERVE-SPARING PROCEDURES IN PRIMARY AND SECONDARY RETROPERITONEAL LYMPHADENECTOMY, British Journal of Urology, 77(1), 1996, pp. 133-137
IS RISK-ORIENTED THERAPY FOR CLINICAL STA GE-I NONSEMINOMA ADVISABLE
Authors: KREGE S RUBBEN H
Citation: S. Krege et H. Rubben, IS RISK-ORIENTED THERAPY FOR CLINICAL STA GE-I NONSEMINOMA ADVISABLE, Der Urologe, 32(3), 1993, pp. 171-176
EXPERIMENTAL AND CLINICAL INVESTIGATIONS ON THE BIOLOGY OF BLADDER-CARCINOMA
Authors: OTTO T GOEPEL M KREGE S RUBBEN H
Citation: T. Otto et al., EXPERIMENTAL AND CLINICAL INVESTIGATIONS ON THE BIOLOGY OF BLADDER-CARCINOMA, Aktuelle Urologie, 24(4), 1993, pp. 192-197
Risultati: 1-14 |